Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL
ClinicalTrials.gov study NCT07074470. IPD Sharing: NO. Countries: 1. Publications: 2.
Identifying the Neural Signature of Exercise to Advance Treatment of PD Cognitive Declines
ClinicalTrials.gov study NCT05972759. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
ClinicalTrials.gov study NCT03881488. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery
ClinicalTrials.gov study NCT05468138. IPD Sharing: NO. Countries: 1. Publications: 5.
Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD
ClinicalTrials.gov study NCT02395029. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT03971214. IPD Sharing: UNDECIDED. Countries: 1. Publications: 33.
Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma
ClinicalTrials.gov study NCT03121677. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06082167. IPD Sharing: NO. Countries: 26. Publications: 1.
Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1
ClinicalTrials.gov study NCT06579196. IPD Sharing: NO. Countries: 1. Publications: 26.
Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1
ClinicalTrials.gov study NCT03313544. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)
ClinicalTrials.gov study NCT01743768. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PD-1 Knockout Engineered T Cells for Muscle-invasive Bladder Cancer
ClinicalTrials.gov study NCT02863913. IPD Sharing: UNDECIDED. Countries: 1. Publications: 7.
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to H
ClinicalTrials.gov study NCT05539872. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Stu
ClinicalTrials.gov study NCT05998122. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors
ClinicalTrials.gov study NCT05809336. IPD Sharing: Not stated. Countries: 1. Publications: 1.
rTMS in Facilitation of Working Memory in PD
ClinicalTrials.gov study NCT03059212. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors
ClinicalTrials.gov study NCT04172506. IPD Sharing: NO. Countries: 1. Publications: 2.
Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation
ClinicalTrials.gov study NCT02149160. IPD Sharing: Not stated. Countries: 6. Publications: 1.
PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC
ClinicalTrials.gov study NCT06206096. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms
ClinicalTrials.gov study NCT01899703. IPD Sharing: YES. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.